|
1
|
Cheung N, Chan L, Thompson A, Cleary ML
and So C: Protein arginine-methyltransferase-dependent oncogenesis.
Nat Cell Biol. 9:1208–1215. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yoshimatsu M, Toyokawa G, Hayami S, Unoki
M, Tsunoda T, Field HI, Kelly JD, Neal DE, Maehara Y, Ponder BA, et
al: Dysregulation of PRMT1 and PRMT6, Type I arginine
methyltransferases, is involved in various types of human cancers.
Int J Cancer. 128:562–573. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mathioudaki K, Scorilas A, Ardavanis A,
Lymberi P, Tsiambas E, Devetzi M, Apostolaki A and Talieri M:
Clinical evaluation of PRMT1 gene expression in breast cancer.
Tumor Biol. 32:575–582. 2011. View Article : Google Scholar
|
|
4
|
Mathioudaki K, Papadokostopoulou A,
Scorilas A, Xynopoulos D, Agnanti N and Talieri M: The PRMT1 gene
expression pattern in colon cancer. Br J Cancer. 99:2094–2099.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Papadokostopoulou A, Mathioudaki K,
Scorilas A, Xynopoulos D, Ardavanis A, Kouroumalis E and Talieri M:
Colon cancer and protein arginine methyltransferase 1 gene
expression. Anticancer Res. 29:1361–1366. 2009.PubMed/NCBI
|
|
6
|
Li B, Liu L, Li X and Wu L: miR-503
suppresses metastasis of hepatocellular carcinoma cell by targeting
PRMT1. Biochem Biophys Res Commun. 464:982–987. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Seligson DB, Horvath S, Shi T, Yu H, Tze
S, Grunstein M and Kurdistani SK: Global histone modification
patterns predict risk of prostate cancer recurrence. Nature.
435:1262–1266. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang H, Huang ZQ, Xia L, Feng Q,
Erdjument-Bromage H, Strahl BD, Briggs SD, Allis CD, Wong J, Tempst
P and Zhang Y: Methylation of histone H4 at arginine 3 facilitating
transcriptional activation by nuclear hormone receptor. Science.
293:853–857. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Strahl BD, Briggs SD, Brame CJ, Caldwell
JA, Koh SS, Ma H, Cook RG, Shabanowitz J, Hunt DF, Stallcup MR and
Allis CD: Methylation of histone H4 at arginine 3 occurs in vivo
and is mediated by the nuclear receptor coactivator PRMT1. Curr
Biol. 11:996–1000. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hong H, Kao C, Jeng MH, Eble JN, Koch MO,
Gardner TA, Zhang S, Li L, Pan CX, Hu Z, et al: Aberrant expression
of CARM1, a transcriptional coactivator of androgen receptor, in
the development of prostate carcinoma and androgen-independent
status. Cancer. 101:83–89. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kim YR, Lee BK, Park RY, Nguyen NT, Bae
JA, Kwon DD and Jung C: Differential CARM1 expression in prostate
and colorectal cancers. BMC Cancer. 10:1972010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Pal S, Baiocchi RA, Byrd JC, Grever MR,
Jacob ST and Sif S: Low levels of miR-92b/96 induce PRMT5
translation and H3R8/H4R3 methylation in mantle cell lymphoma. EMBO
J. 26:3558–3569. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lee J, Sayegh J, Daniel J, Clarke S and
Bedford MT: PRMT8, a new membrane-bound tissue-specific member of
the protein arginine methyltransferase family. J Biol Chem.
280:32890–32896. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Goulet I, Gauvin G, Boisvenue S and Côté
J: Alternative splicing yields protein arginine methyltransferase 1
isoforms with distinct activity, substrate specificity, and
subcellular localization. J Biol Chem. 282:33009–33021. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhong J, Cao RX, Zu XY, Hong T, Yang J,
Liu L, Xiao XH, Ding WJ, Zhao Q, Liu JH and Wen GB: Identification
and characterization of novel spliced variants of PRMT2 in breast
carcinoma. FEBS J. 279:316–335. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Scorilas A, Black MH, Talieri M and
Diamandis EP: Genomic organization, physical mapping, and
expression analysis of the human protein arginine methyltransferase
1 gene. Biochem Biophys Res Commun. 278:349–359. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hernandez S and Dominko T: Novel protein
arginine methyltransferase 8 isoform is essential for cell
proliferation. J Cell Biochem. 117:2056–2066. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Uhlén M, Fagerberg L, Hallström BM,
Lindskog C, Oksvold P, Mardinoglu A, Sivertsson Å, Kampf C,
Sjöstedt E, Asplund A, et al: Proteomics. Tissue-based map of the
human proteome. Science. 347:12604192015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Györffy B, Lanczky A, Eklund AC, Denkert
C, Budczies J, Li Q and Szallasi Z: An online survival analysis
tool to rapidly assess the effect of 22,277 genes on breast cancer
prognosis using microarray data of 1,809 patients. Breast Cancer
Res Treat. 123:725–731. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Dawson MA and Kouzarides T: Cancer
epigenetics: From mechanism to therapy. Cell. 150:12–27. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sharma S, Kelly TK and Jones PA:
Epigenetics in cancer. Carcinogenesis. 31:27–36. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kousaka A, Mori Y, Koyama Y, Taneda T,
Miyata S and Tohyama M: The distribution and characterization of
endogenous protein arginine N-methyltransferase 8 in mouse CNS.
Neuroscience. 163:1146–1157. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sammons MA, Zhu J and Berger SL: A
chromatin-focused siRNA screen for regulators of p53-dependent
transcription. G3 (Bethesda). 6:2671–2678. 2016. View Article : Google Scholar : PubMed/NCBI
|
